Nkarta, Inc. (NKTX)

2.76 +0.01 (+0.36%) USD  |  NASDAQ  |  Aug 28, 16:00
2.77 +0.01 (+0.36%) After-Hours: 20:00
More

Nkarta Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for NKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 17, 2026 --
August 13, 2026 --
August 11, 2026 --
June 23, 2026 --
June 22, 2026 --
May 13, 2026 --
May 12, 2026 --
April 16, 2026 --
April 10, 2026 --
March 31, 2026 --
March 26, 2026 --
February 20, 2026 --
December 31, 2025 --
November 20, 2025 --
November 11, 2025 --
Date Value
August 13, 2025 --
July 31, 2025 --
June 30, 2025 --
June 09, 2025 --
May 15, 2025 --
May 08, 2025 --
March 31, 2025 --
March 27, 2025 --
February 21, 2025 --
February 13, 2025 --
December 31, 2024 --
August 16, 2024 --
August 14, 2024 --
August 13, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. Upgrade
Theriva Biologics, Inc. Upgrade
Unicycive Therapeutics, Inc. Upgrade
OnKure Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade